CLINICAL ROLE -
What Role Do Pharmacists Play in Educating About Nutraceuticals?
Patients can use guidance about what vitamin products to select for their use.
Getting Patients to Take an Active Role in Their Own Care
Eric Peacock, co-founder and CEO of MyHealthTeams, discusses the importance of specialty pharmacies collaborating with patients in their care.
Maintaining Adherence as Out of Pocket Costs Rise
Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how specialty pharmacy can help patients manage high out of pocket costs for specialty drugs.
What Is the Role of the Pharmacist in Explaining CVD Medicines?
In this clip taken at APhA 2017, Evan Sisson, PharmD, of VCU School of Pharmacy discusses the role of the pharmacist in counseling patients about cardiovascular medication and nutraceutical use.
The Long-Term Impact of Biosimilars
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
How Can Pharmacists Help Deal with Clinical Inertia?
Pharmacists play an important role in helping to deal with clinical inertia.
What Treatment Options Are Being Studied for Patients with Type 2 Diabetes?
There are several new options coming down the pipeline for patients with type 2 diabetes.
Are There Knowledge Gaps in Terms of Managing Patients with Diabetes?
Continuing education remains an important part of a pharmacist's life, particularly those dealing with an ever-increasing population of patients with diabetes.
What's New in the Treatment Development Pipeline for Patients with Diabetes?
There are several new treatments in the pipeline that hold promise for patients with type 2 diabetes.
What Role Will Pharmacists Play in Diabetes Management in the Future?
Sessions focuses on new diabetes treatment options.
What Options Should Pharmacists Consider When Tapering Patients from Opioids?
In this clip, Jeffrey Fudin, PharmD, who spoke at APHA 2017 on opioid tapering, discusses options pharmacists should consider when tapering patients.
What Should Pharmacists Consider When Discussing Abuse-Deterrent Opioid Formulations?
In this clip, Jeffrey Fudin, PharmD, discusses available options in abuse-deterrent formulations of opioids.
Pharmacy Week in Review: March 24, 2017
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
How Value-based Care Could Affect Specialty Pharmacy
Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.
Effective Medication Therapy Management in Specialty Pharmacy
Jonathan Van Lare, PharmD, director of Clincal Services at Pharmacy Advantage, discusses the elements of a successful specialty pharmacy therapy management program.
Scrutiny Continues to Grow Around the Cost of Specialty Drugs
Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.
Greater Competition and Specialty Drug Costs
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses whether increased competition for specialty drugs can lower costs.
Pharmacy Week in Review: March 17, 2017
How Can Pharmacists Maintain Adherence?
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses methods pharmacists can employ to maintain adherence.
Quality Metrics That Define Specialty Pharmacy
Daniel P. Kus, BS Pharm, RPh, vice president, Pharmacy Advantage, discusses key quality measures that define successful specialty pharmacies.
High Cost Impacts PCSK9 Inhibitor Access
Mark Tesell, PharmD, BCPS, discusses how the high cost of PCSK9 inhibitors effected uptake of the cholesterol-lowering drug.
Access to High Cost Drugs Remains a Challenge in Specialty
Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.
The Key to Effective Patient Management in Specialty Pharmacy
Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.
Demonstrating Quality Under a Value-Based Insurance Design
Marc O'Connor, COO and chief strategy officer for Curant Health, discusses how specialty pharmacies can demonstrate value as the use of value-based care designs increase.
Managing Patients on PCSK9 Inhibitors
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses utilization management issues with a PCSK9 inhibitor regimen for high cholesterol.
Challenges Managing Patients in Long-Term Care
Deborah Michaelson, MS, RPh, discusses various challenges that accompany patient support in the long-term care setting.
Challenges Integrating Technology into Specialty Pharmacy
Gregory R. Morris, chief commercial officer at VirMedica, discusses hurdles with the use of eAccess technology in specialty pharmacy.
How to Improve Patient Access to Expensive Drugs
Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses how specialty pharmacies can help patients access high cost specialty drugs.
How Collaborative Care Programs Can Benefit Specialty Pharmacy
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how collaborative care programs among providers can benefit patients undergoing treatment.
Medicare Part D and Oncology
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.
